Article thumbnail
Location of Repository

The CUGBP2 Splicing Factor Regulates an Ensemble of Branchpoints from Perimeter Binding Sites with Implications for Autoregulation

By Jill A. Dembowski and Paula J. Grabowski


Alternative pre-mRNA splicing adjusts the transcriptional output of the genome by generating related mRNAs from a single primary transcript, thereby expanding protein diversity. A fundamental unanswered question is how splicing factors achieve specificity in the selection of target substrates despite the recognition of information-poor sequence motifs. The CUGBP2 splicing regulator plays a key role in the brain region-specific silencing of the NI exon of the NMDA R1 receptor. However, the sequence motifs utilized by this factor for specific target exon selection and its role in splicing silencing are not understood. Here, we use chemical modification footprinting to map the contact sites of CUGBP2 to GU-rich motifs closely positioned at the boundaries of the branch sites of the NI exon, and we demonstrate a mechanistic role for this specific arrangement of motifs for the regulation of branchpoint formation. General support for a branch site-perimeter–binding model is indicated by the identification of a group of novel target exons with a similar configuration of motifs that are silenced by CUGBP2. These results reveal an autoregulatory role for CUGBP2 as indicated by its direct interaction with functionally significant RNA motifs surrounding the branch sites upstream of exon 6 of the CUGBP2 transcript itself. The perimeter-binding model explains how CUGBP2 can effectively embrace the branch site region to achieve the specificity needed for the selection of exon targets and the fine-tuning of alternative splicing patterns

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1997). A complex intronic splicing enhancer from the csrc pre-mRNA activates inclusion of a heterologous exon.
  2. (1998). A cooperative interaction between U2AF65 and mBBP/SF1 facilitates branchpoint region recognition.
  3. (1997). A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
  4. (2005). A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
  5. (2004). A pathway of sequential arginine-serine-rich domainsplicing signal interactions during mammalian spliceosome assembly.
  6. (2008). A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.
  7. (1998). A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site.
  8. (2002). Alternative pre-mRNA splicing and proteome expansion in metazoans.
  9. (1989). Alternative production of calcitonin and CGRP mRNA is regulated at the calcitonin-specific splice acceptor.
  10. (2001). Alternative splicing: increasing diversity in the proteomic world.
  11. (2006). An RNA map predicting Nova-dependent splicing regulation.
  12. (2004). Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly.
  13. (2009). Assembly of ribosomes and spliceosomes: complex ribonucleoprotein machines.
  14. (2004). Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay.
  15. (1988). Barta A
  16. (1989). Branch point selection in alternative splicing of tropomyosin pre-mRNAs.
  17. (1991). Control of alternative splicing by the differential binding of U1 small nuclear ribonucleoprotein particle.
  18. (1995). Cooperation of 59 and 39 processing sites as well as intron and exon sequences in calcitonin exon recognition.
  19. (1997). Cross-intron bridging interactions in the yeast commitment complex are conserved in mammals.
  20. (1999). Crystal structure of the two-RRM domain of hnRNP A1 (UP1) complexed with singlestranded telomeric DNA.
  21. (1991). Deregulation of alternative processing of Calcitonin/ CGRP-I pre-mRNA by a single point mutation.
  22. (1994). Direct interactions between pre-mRNA and six U2 small nuclear ribonucleoproteins during spliceosome assembly.
  23. (2007). Discovery and analysis of evolutionarily conserved intronic splicing regulatory elements.
  24. (2002). Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing.
  25. (2005). Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development.
  26. (2007). Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
  27. (2006). ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.
  28. (1990). Exon definition may facilitate splice site selection in RNAs with multiple exons.
  29. (2007). Exon silencing by UAGG motifs in response to neuronal excitation.
  30. (2006). Fox-2 mediates epithelial cellspecific fibroblast growth factor receptor 2 exon choice.
  31. (2007). hnRNP proteins and splicing control.
  32. (2008). Human branch point consensus sequence is yUnAy.
  33. (1996). Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy.
  34. (1996). Identification of proteins that interact with exon sequences, splice sites, and the branchpoint sequence during each stage of spliceosome assembly.
  35. (2005). Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment.
  36. (1996). Interaction of U2AF65 RS region with pre-mRNA branch point and promotion of base pairing with U2 snRNA [corrected].
  37. (1998). Mechanical devices of the spliceosome: motors, clocks, springs, and things.
  38. (2003). Mechanisms of alternative pre-messenger RNA splicing.
  39. (2005). Neuronal proteins custom designed by alternative splicing.
  40. (2007). Neuronal regulation of alternative pre-mRNA splicing.
  41. (2005). Nova autoregulation reveals dual functions in neuronal splicing.
  42. (2003). Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer.
  43. (2000). Probing RNA structure and RNA-ligand complexes with chemical probes.
  44. (2002). Region-specific alternative splicing in the nervous system: implications for regulation by the RNA-binding protein NAPOR. RNA 8: 671–685. Branchpoint Regulation by Perimeter Binding
  45. (2002). Regulation of alternative splicing of alpha-actinin transcript by Bruno-like proteins.
  46. (2000). Sorting out the complexity of SR protein functions.
  47. (2003). Splicing double: insights from the second spliceosome.
  48. (2006). Structural basis for polypyrimidine tract recognition by the essential pre-mRNA splicing factor U2AF65.
  49. (2001). Structural basis for recognition of the intron branch site RNA by splicing factor 1.
  50. (2005). Structure of PTB bound to RNA: specific binding and implications for splicing regulation.
  51. (2001). The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.
  52. (1992). U1 snRNP targets an essential splicing factor, U2AF65, to the 39 splice site by a network of interactions spanning the exon.
  53. (2007). Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay.
  54. (2005). Understanding alternative splicing: towards a cellular code.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.